NZCR was formed in 2020 by the merger of Auckland Clinical Studies (ACS) and Christchurch Clinical Studies Trust (CCST), and is New Zealand's leading early phase stage clinical research provider.
NZCR was formed in 2020 by the merger of Auckland Clinical Studies (ACS) and Christchurch Clinical Studies Trust (CCST), and is New Zealand(TM)s leading early phase stage clinical research provider.
The merger brings together over 35 years combined research excellence, a track record of completing over 750 trials involving over 15,000 participants and provides expanded scale and capability.
With physician led, world class research units located in Auckland, Christchurch, Wellington, and Hamilton, NZCR conducts complex early phase clinical research in healthy participant and patient populations.
We partner with global pharmaceutical and biotechnology companies to deliver excellence in clinical research and investigate potential new medicines by conducting clinical studies in Auckland, Hamilton, Wellington, and Christchurch.
